Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

European Medical Information Framework

EMIF

In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts. However, data sources are typically fragmented and contain information...

Funding Programme
IMI
Start Date
End Date
Total Funding
€ 53 642 677

implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC

ADOPT BBMRI-ERIC

BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical...

Funding Programme
EU-H2020
Start Date
End Date
Total Funding
€ 4 949 449

Improving health services for European citizens with dementia: Development of best practice strategies for the transition from ambulatory to institutional long-term care facilities

RIGHTTIMEPLACECARE

Given the increasing number of patients/consumers with dementia, political action is urgently required to prepare the health care services throughout Europe to deliver cost effective high quality long-term care to people concerned. Currently there is a lack of clinical research data of patients/consumers and informal caregivers to develop best...

Funding Programme
EU-FP7
Start Date
End Date
Total Funding
€ 3 897 650
European Countries Involved

Innovative Intracranial Pressure and Volume Wave Monitoring System

DynICP

In DynICP, we propose to develop an advanced, portable prototype of a non-invasive intracranial dynamic pressure (dynamic ICP) diagnosing and monitoring device which can be used at hospitals, point of care as well as at home. This device will consist of a wearable head gear capable of precise positioning of two ultrasonic transducers, software and...

Funding Programme
EU-FP7
Start Date
End Date
Total Funding
€ 1 483 002
European Countries Involved

MRI analysis tool for early detection of dementia

MATEDD

Worldwide due to population ageing there will be 75 million patients with Alzheimer's disease by 2030. Alzheimer's is a disease described by accelerated brain ageing which leads to decline in both memory and cognitive skills, thus affecting everyday activities of those suffering. On average over 60% of patients do not receive a diagnosis and...

Funding Programme
EU-Horizon Europe
Start Date
End Date
Total Funding
€ 75 000
European Countries Involved

Non-Animal Platform for Nanoparticle-Based Delivery across the blood-brain barrier Interface with Vehicle Evolution

NAP4DIVE

The blood-brain barrier (BBB) is a major obstacle in treating diseases of the central nervous system (CNS) such as Parkinson's, Alzheimer's, Schizophrenia and brain cancer, affecting 180 million Europeans with less than 5% of current candidate drugs effectively reaching the brain. NAP4DIVE strives to revolutionize the traditionally expensive and...

Funding Programme
EU-Horizon Europe
Start Date
End Date
Total Funding
€ 7 767 276
European Countries Involved

OLIGOPEPTIDASE INHIBITORS IN BRAIN FUNCTION AND DYSFUNCTION: TOWARDS NEW THERAPEUTIC STRATEGIES FOR NEUROPROTECTION

NEUROPRO

At present more than 5 million people in the EU suffer from dementia and other neurodegenerative diseases and that number will grow as the average age of the population continues to increase. The efficacy of current medicines is limited and new therapeutic targets are sorely needed. Several independent lines of evidence have established an...

Funding Programme
EU-FP7
Start Date
End Date
Total Funding
€ 6 290 178
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).